Gemcitabine and Liposomal Doxorubicin (GemDox) for the Treatment of Relapsed and Refractory T-Cell Lymphomas

被引：0
|
作者：
Braunstein, Zachary [1 ]
Waller, Allyson [2 ]
Dotson, Emily [3 ]
McLaughlin, Eric [4 ]
Hanel, Walter [5 ]
Reneau, John C. [5 ]
Addison, Daniel [6 ]
Porcu, Pierluigi [7 ]
Brammer, Jonathan E. [5 ]
机构：
[1] Ohio State Univ, James Canc Hosp, Wexner Med Ctr, Columbus, OH USA
[2] Ohio State Univ, Ctr Comprehens Canc, Dept Pharm, Columbus, OH USA
[3] Ohio State Univ, Wexner Med Ctr, Columbus, OH USA
[4] Ohio State Univ, Ctr Biostat, Columbus, OH USA
[5] Ohio State Univ, Wexner Med Ctr, James Canc Ctr, Columbus, OH USA
[6] Ohio State Univ, Dept Cardiol, Wexner Med Ctr, Columbus, OH USA
[7] Thomas Jefferson Univ, Dept Med Oncol, Philadelphia, PA USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-184583
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [31] A Multicenter Phase I Dose-Finding and Preliminary Efficacy Study of the Histone Deacetylase Inhibitor Romidepsin in Combination with Pegylated Liposomal Doxorubicin for the Treatment of Adults with Relapsed or Refractory Cutaneous and Peripheral T-Cell Lymphomas
    Ai, Weiyun
    Porcu, Pierluigi
    Berry, Wade
    Engleman, Juliana
    Wieduwilt, Matthew J.
    Brammer, Jonathan E.
    BLOOD, 2017, 130
  • [32] Treatment of relapsing or recalcitrant cutaneous T-cell lymphoma with pegylated liposomal doxorubicin
    Wollina, U
    Graefe, T
    Karte, K
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2000, 42 (01) : 40 - 46
  • [33] Pegylated liposomal doxorubicin for cutaneous T-cell lymphoma
    不详
    JOURNAL OF DRUGS IN DERMATOLOGY, 2008, 7 (08) : 809 - 809
  • [34] Pegylated liposomal doxorubicin (PLD) as an alternative treatment of cutaneous T-cell lymphoma
    Quereux, G.
    Khammari, A.
    Nguyen, J. M.
    Benmiloud, M.
    Dreno, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [35] Real-life experience of using pegylated liposomal doxorubicin in primary cutaneous T-cell lymphomas
    Falkenhain-Lopez, Daniel
    Puerta-Pena, Mario
    Fulgencio-Barbarin, Jon
    Sanchez-Velazquez, Alba
    Vico-Alonso, Cristina
    Postigo-Llorente, Concepcion
    Ortiz-Romero, Pablo L.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2022, 47 (09) : 1712 - 1715
  • [36] Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma
    Houot, Roch
    Poeschel, Viola
    Altmann, Bettina
    Angel, Stephanie
    Thurner, Lorenz
    Illmer, Thomas
    Andre, Marc
    Dreyling, Martin
    Maisonneuve, Herve
    Tilly, Herve
    Mayer, Stephanie
    Casasnovas, Olivier
    Le Gouill, Steven
    Offner, Fritz
    Cartron, Guillaume
    Kerkhoff, Andrea
    Weber, Thomas
    Hoffmann, Joerg
    Ziepert, Marita
    Klapper, Wolfram
    Itti, Emmanuel
    Hellwig, Dirk
    Natchkebia, Giorgi
    de Leval, Laurence
    Rosenwald, Andreas
    Haioun, Corinne
    Dercle, Laurent
    Gaulard, Philippe
    Held, Gerhard
    HEMASPHERE, 2022, 6 (02):
  • [37] Romidepsin in relapsed/refractory T-cell lymphomas: Italian experience and results of a named patient program
    Zinzani, Pier Luigi
    Pellegrini, Cinzia
    Cerciello, Giuseppe
    Monaco, Federico
    Volpetti, Stefano
    Peli, Annalisa
    Angelucci, Emanuele
    Corradini, Paolo
    Cox, Maria Christina
    Guarini, Attilio
    Musso, Maurizio
    Bresciani, Paola
    Amato, Gabriella
    Billio, Atto
    Caparrotti, Giuseppe
    Figuera, Amalia
    Nassi, Luca
    Gaudio, Francesco
    Grossi, Alberto
    Onida, Francesco
    Merli, Michele
    Rigacci, Luigi
    Argnani, Lisa
    LEUKEMIA & LYMPHOMA, 2016, 57 (10) : 2370 - 2374
  • [38] Profile of belinostat for the treatment of relapsed or refractory peripheral T-cell lymphoma
    Bodiford, Andrew
    Bodge, Megan
    Talbott, Mahsa S.
    Reddy, Nishitha M.
    ONCOTARGETS AND THERAPY, 2014, 7 : 1971 - 1977
  • [39] Ifosfamide and etoposide in advanced-stage, relapsed or refractory primary cutaneous T-cell lymphomas
    De Masson, Adele
    Dangien, Ambre
    Ram-Wolff, Caroline
    Battistella, Maxime
    Moins-Teisserenc, Helene
    Bagot, Martine
    EUROPEAN JOURNAL OF CANCER, 2021, 156 : S22 - S22
  • [40] Novel Agents in the Treatment of Relapsed or Refractory Peripheral T-Cell Lymphoma
    Marchi, Enrica
    Raufi, Alexander G.
    O'Connor, Owen A.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 31 (02) : 359 - +
12345